Taken together, our findings suggest that admission values of lymphocyte counts, neutrophil-to-lymphocyte ratio and the levels of some inflammatory markers (IL8/CXCL8, MCP-1/CCL2, IL-10, and C-reactive protein) may be useful as COVID-19 outcome predictors during hospitalization. The gene discussed is CCL2; the disease is COVID-19.